GLP-1 participates in prebiotic-driven decreases in appetite, fat mass and hepatic insulin resistance, whereas GLP-2, as mentioned before, contributes to the reduced permeability of the intestinal wall and endotoxemia that are associated with obesity (Cani et al., 2006, 2009b). This evidence concerns the gene GCG and obesity disorder.